Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial

Autor: Nijssen, Estelle C, Rennenberg, Roger J, Nelemans, Patty J, Essers, Brigitte A, Janssen, Marga M, Vermeeren, Marja A, Ommen, Vincent van, Wildberger, Joachim E
Zdroj: In The Lancet 1-7 April 2017 389(10076):1312-1322
Databáze: ScienceDirect